Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

[Changes of left ventricular myocardial collagen fibers and osteopontin expression in hypertrophic cardiomyopathy].

Tang DW, Lin GS, Huang JL, Liu C, Hao B, Yu YG, Kong XP, Quan L, Liao XB, Luo B.

Fa Yi Xue Za Zhi. 2012 Aug;28(4):247-51. Chinese.

PMID:
23033660
2.

[Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].

Kawanishi H, Yokota Y, Hayakawa M, Kaku K, Kumaki T, Matsumoto K, Fujitani K, Ito Y, Inoh T, Fukuzaki H.

J Cardiogr. 1983 Sep;13(3):537-50. Japanese.

PMID:
6235295
3.

Prognostic value of the collagen volume fraction in hypertrophic cardiomyopathy.

Arteaga E, de Araújo AQ, Bernstein M, Ramires FJ, Ianni BM, Fernandes F, Mady C.

Arq Bras Cardiol. 2009 Mar;92(3):210-4, 216-20. English, Spanish.

4.

Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.

Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A, Maschio AD.

Heart. 2009 Mar;95(3):228-33. doi: 10.1136/hrt.2008.142562. Epub 2008 Aug 15.

PMID:
18708417
5.

Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.

Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ.

Eur Heart J. 2009 Jul;30(13):1627-34. doi: 10.1093/eurheartj/ehp121. Epub 2009 Apr 30.

6.
7.

S100A4 and P53 in myocardial collagen fibers of hypertrophic cardiomyopathy : Expression and clinical significance.

Qi X, Han J, Zhao P, Dong X, Gong S.

Herz. 2016 Sep;41(6):530-3. doi: 10.1007/s00059-015-4397-x. Epub 2016 Jan 18.

PMID:
26781584
8.

Characterization and quantitation of extracellular collagen matrix in myocardium of pigs with spontaneously occurring hypertrophic cardiomyopathy.

Chiu YT, Liu SK, Liu M, Chen SP, Lin YH, Mao SJ, Chu R.

Cardiovasc Pathol. 1999 May-Jun;8(3):169-75.

PMID:
10722240
9.

[Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].

Sugihara N, Shimizu M, Suematsu T, Horita Y, Shimizu K, Ohsato K, Shibayama S, Nakao T, Kitamura M, Takeda R.

J Cardiol. 1990;20(1):71-81. Japanese.

PMID:
2151236
10.

[Regression of giant negative T waves in hypertrophic cardiomyopathy: cases simulating either dilated cardiomyopathy or severe coronary artery stenosis].

Horita Y, Konishi K, Osato K, Nakao T, Namura M, Kanaya H, Ohka T, Genda A, Takeda R.

J Cardiol. 1988 Sep;18(3):875-85. Japanese.

PMID:
3249296
11.

[Serial changes in left ventricular configuration and function in hypertrophic cardiomyopathy].

Horita Y, Genda A, Shimizu Y, Sugihara N, Suematsu T, Kita Y, Takeda R.

J Cardiol. 1988 Sep;18(3):651-64. Japanese.

PMID:
3249282
12.

[Relationships between distribution of disorganized cardiac muscle cells and disease state in hypertrophic cardiomyopathy].

Morimoto S, Sekiguchi M, Nishikawa T.

J Cardiol Suppl. 1987;16:9-24. Japanese.

PMID:
3509686
13.

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Cannon RO 3rd, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE.

Circulation. 1985 Feb;71(2):234-43.

PMID:
4038383
14.

Localization of type IV collagen alpha chain in the myocardium of dilated and hypertrophic cardiomyopathy.

Watanabe T, Kusachi S, Yamanishi A, Kumashiro H, Nunoyama H, Sano I, Nakahama M, Murakami T, Naito I, Ninomiya Y, Tsuji T.

Jpn Heart J. 1998 Nov;39(6):753-62.

PMID:
10089937
15.

Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.

Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, Mukoyama M, Nakao K, Imura H, Sasayama S.

Circulation. 1993 Aug;88(2):372-80.

PMID:
8339400
16.

Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias.

Limongelli G, Pacileo G, Cerrato F, Verrengia M, Di Simone A, Severino S, Sarubbi B, Calabrò R.

J Am Soc Echocardiogr. 2003 Aug;16(8):803-7.

PMID:
12878988
17.

Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy.

Takemura G, Fujiwara H, Mukoyama M, Saito Y, Nakao K, Kawamura A, Ishida M, Kida M, Uegaito T, Tanaka M, et al.

Circulation. 1991 Jan;83(1):181-90.

PMID:
1824622
18.

Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy.

Nakamura K, Kusano KF, Matsubara H, Nakamura Y, Miura A, Nishii N, Banba K, Nagase S, Miyaji K, Morita H, Saito H, Emori T, Ohe T.

J Card Fail. 2005 Mar;11(2):117-23.

PMID:
15732031
19.

Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis.

Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, Riegger G, Luchner A.

Heart. 2006 Oct;92(10):1447-51. Epub 2006 Apr 10.

20.

Subvalvular aortic stenosis as a cause of sudden death: two case reports.

Turan AA, Guven T, Karayel F, Pakis I, Gurpinar K, Ozaslan A.

Am J Forensic Med Pathol. 2006 Mar;27(1):90-2.

PMID:
16501359
Items per page

Supplemental Content

Write to the Help Desk